0001604950-16-000001.txt : 20160204 0001604950-16-000001.hdr.sgml : 20160204 20160204172130 ACCESSION NUMBER: 0001604950-16-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20160204 DATE AS OF CHANGE: 20160204 EFFECTIVENESS DATE: 20160204 FILER: COMPANY DATA: COMPANY CONFORMED NAME: scPharmaceuticals Inc. CENTRAL INDEX KEY: 0001604950 IRS NUMBER: 465184075 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-256791 FILM NUMBER: 161389411 BUSINESS ADDRESS: STREET 1: 75 ARLINGTON STREET STREET 2: SUITE 500 CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 617-517-0730 MAIL ADDRESS: STREET 1: 75 ARLINGTON STREET STREET 2: SUITE 500 CITY: BOSTON STATE: MA ZIP: 02116 D 1 primary_doc.xml X0707 D LIVE 0001604950 scPharmaceuticals Inc. 131 Hartwell Avenue Suite 215 Lexington MA MASSACHUSETTS 02421 617-517-0730 DELAWARE None None Corporation true 2014 Pieter Muntendam 131 Hartwell Avenue Suite 215 Lexington MA MASSACHUSETTS 02421 Executive Officer Director Kush Parmar 131 Hartwell Avenue Suite 215 Lexington MA MASSACHUSETTS 02421 Director Mette Kirstine Agger 131 Hartwell Avenue Suite 215 Lexington MA MASSACHUSETTS 02421 Director Leonard Schaeffer 131 Hartwell Avenue Suite 215 Lexington MA MASSACHUSETTS 02421 Director Dorothy Coleman 131 Hartwell Avenue Suite 215 Lexington MA MASSACHUSETTS 02421 Director Pharmaceuticals Decline to Disclose 06b false 2016-01-21 false true true false 0 7500000 3600000 3900000 false 12 0 0 171800 true Proceeds to be used for general working capital purposes, including the payment of compensation to certain of the directors and officers of the corporation listed as Related Persons in Item 3. false scPharmaceuticals Inc. /s/ Pieter Muntendam Pieter Muntendam President 2016-02-04